Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Hypertension in Transplant Recipients
  • Published:

Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates

Abstract

Cyclosporin-induced hypertension is a major complication of immunosuppression in transplant recipients but its pathophysiology is only partly understood. Cyclosporin reduces endothelium-dependent vasodilation and increases endothelin synthesis and release, which may contribute to this hypertension. We examined the effects of: (1) nitric oxide enhancement with L-arginine administration and antagonism with N-nitro-L-arginine; and (2) chronic endothelin receptor blockade with the non-peptide endothelin receptor antagonist, bosentan, in two animal models of cyclosporin-induced hypertension. Cyclosporin, administered daily to female Wistar rats (10 mg/kg per day for 30 days, s.c.) and to marmosets (30 mg/kg per day for 20 days, p.o.) significantly elevated tail cuff systolic blood pressure (BP). L-arginine (250 mg/kg, in saline, i.p.), N-nitro-L-arginine (25 mg/kg, in saline, i.p.), bosentan (100 mg/kg, in arabic gum, p.o.) or vehicle were given daily to the rats during the last week of cyclosporin treatment. Marmosets received L-arginine (300 mg/kg, in water, p.o.), bosentan (100 mg/kg/day in arabic gum, p.o.) or vehicle for the last 7 days of cyclosporin treatment. L-arginine, but not saline alone significantly lowered BP in the cyclosporin-hypertensive rats from 129 ± 2 mm Hg to 122 ± 3 mm Hg (P < 0.05), and cyclosporin-hypertensive marmosets from 156 ± 2 mm hg to 139 ± 4 mm hg (P < 0.01). nola significantly increased systolic bp in cyclosporin-treated (from 133 ± 2 mm hg at week 3 to 142 ± 3 mm hg, P < 0.05) and control rats (from 124.0 ± 2 mm hg to 134 ± 2 mm hg, P < 0.05) indicating that nitric oxide synthesis in cyclosporin-hypertensive rats could be further antagonised. bosentan, but not arabic gum alone, also lowered bp in the cyclosporin-hypertensive rats from 134 ± 1 mm hg to 122 ± 3 mm hg (P < 0.01), and cyclosporin-hypertensive marmosets from 156 ± 2 mm hg to 139 ± 4 mm hg (P < 0.01). these results support the roles of both increased endothelin synthesis and decreased nitric oxide activity in the pathogenesis of cyclosporin a-induced hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartholomeusz, B., Hardy, K., Nelson, A. et al. Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates. J Hum Hypertens 12, 839–844 (1998). https://doi.org/10.1038/sj.jhh.1000709

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1000709

Keywords

This article is cited by

Search

Quick links